BioCentury
ARTICLE | Company News

Pacific, Roche enter IVD deal

September 26, 2013 1:11 AM UTC

Pacific Biosciences of California Inc. (NASDAQ:PACB) jumped $2.52 (73%) to $5.98 on Wednesday after partnering with Roche Diagnostics to develop diagnostic products, including sequencing systems and c...